Mark Wheelis makes a thoroughly scientific case for deterring the covert use of biological weapons through a program of global epidemiological surveillance, thoughtfully laid out in terms of function, organization, and goals. In tactical terms, however, it seems a bit like the tail of biological weapons control wagging the dog of the “other benefits”—as Dr. Wheelis recognizes in discussing the latter. The driving force for such a program would surely be its benefits for world public and economic health.
